[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-10-31

AUTHORS

Sungeun Kim, June-Key Chung, Soon-Beom Kang, Moon-Hong Kim, Jae Min Jeong, Dong Soo Lee, Myung Chul Lee

ABSTRACT

The aim of this study was to compare the prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) with that of second-look laparotomy (SLL) in patients with advanced ovarian carcinoma following primary chemotherapy. Fifty-five patients who had undergone cytoreductive surgery and adjuvant chemotherapy for advanced ovarian carcinoma were enrolled in the study. Thirty patients underwent SLL after primary treatment (SLL group), while 25 underwent FDG PET after primary treatment without SLL (PET group). We retrospectively reviewed the medical records of the 55 patients for comparison of progression-free interval and disease-free interval between the two groups. Ovarian carcinomas recurred in 37 of the 55 patients. When the progression-free interval and the disease-free interval in patients in the PET group were compared with those in the SLL group, no significant differences were observed. The progression-free interval in the PET and SLL groups were 28.8±12.7 months and 30.6±13.7 months, respectively (P=0.29). The disease-free interval in the negative PET group was 40.5±11.6 months, and that in the negative SLL group was 48.6±12.1 months (P=0.12). In conclusion, FDG PET has a similar prognostic value to SLL, and can substitute for SLL in the follow-up of patients who have had ovarian carcinoma, especially when there is a high risk for recurrence. More... »

PAGES

196-201

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-003-1367-y

DOI

http://dx.doi.org/10.1007/s00259-003-1367-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007292516

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15129701


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analgesics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Korea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Laparotomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ovarian Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Second-Look Surgery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, Emission-Computed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University Hospital, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea", 
            "Cancer Research Institute, Seoul National University Hospital, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Sungeun", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University Hospital, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea", 
            "Cancer Research Institute, Seoul National University Hospital, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "June-Key", 
        "id": "sg:person.0751347234.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Soon-Beom", 
        "id": "sg:person.012160052074.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012160052074.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Moon-Hong", 
        "id": "sg:person.01102164107.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102164107.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeong", 
        "givenName": "Jae Min", 
        "id": "sg:person.01301360400.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.412484.f", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Myung Chul", 
        "id": "sg:person.01337220140.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337220140.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-001-0750-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006601848", 
          "https://doi.org/10.1007/s00259-001-0750-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-10-31", 
    "datePublishedReg": "2003-10-31", 
    "description": "The aim of this study was to compare the prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) with that of second-look laparotomy (SLL) in patients with advanced ovarian carcinoma following primary chemotherapy. Fifty-five patients who had undergone cytoreductive surgery and adjuvant chemotherapy for advanced ovarian carcinoma were enrolled in the study. Thirty patients underwent SLL after primary treatment (SLL group), while 25 underwent FDG PET after primary treatment without SLL (PET group). We retrospectively reviewed the medical records of the 55 patients for comparison of progression-free interval and disease-free interval between the two groups. Ovarian carcinomas recurred in 37 of the 55 patients. When the progression-free interval and the disease-free interval in patients in the PET group were compared with those in the SLL group, no significant differences were observed. The progression-free interval in the PET and SLL groups were 28.8\u00b112.7 months and 30.6\u00b113.7 months, respectively (P=0.29). The disease-free interval in the negative PET group was 40.5\u00b111.6 months, and that in the negative SLL group was 48.6\u00b112.1 months (P=0.12). In conclusion, FDG PET has a similar prognostic value to SLL, and can substitute for SLL in the follow-up of patients who have had ovarian carcinoma, especially when there is a high risk for recurrence.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-003-1367-y", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "keywords": [
      "second-look laparotomy", 
      "advanced ovarian carcinoma", 
      "disease-free interval", 
      "progression-free interval", 
      "ovarian carcinoma", 
      "SLL group", 
      "FDG-PET", 
      "prognostic value", 
      "primary treatment", 
      "fluorine-18 fluorodeoxyglucose positron emission tomography", 
      "PET group", 
      "fluorodeoxyglucose positron emission tomography", 
      "underwent FDG-PET", 
      "similar prognostic value", 
      "positron emission tomography", 
      "primary chemotherapy", 
      "adjuvant chemotherapy", 
      "cytoreductive surgery", 
      "medical records", 
      "high risk", 
      "patients", 
      "carcinoma", 
      "emission tomography", 
      "months", 
      "laparotomy", 
      "chemotherapy", 
      "significant differences", 
      "treatment", 
      "group", 
      "PET", 
      "interval", 
      "surgery", 
      "recurrence", 
      "tomography", 
      "risk", 
      "study", 
      "conclusion", 
      "aim", 
      "differences", 
      "records", 
      "values", 
      "substitute", 
      "comparison"
    ], 
    "name": "[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma", 
    "pagination": "196-201", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007292516"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-003-1367-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15129701"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-003-1367-y", 
      "https://app.dimensions.ai/details/publication/pub.1007292516"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_376.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-003-1367-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-003-1367-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-003-1367-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-003-1367-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-003-1367-y'


 

This table displays all metadata directly associated to this object as RDF triples.

236 TRIPLES      21 PREDICATES      90 URIs      80 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-003-1367-y schema:about N075091a5461543cb9ed2663c34fa10b5
2 N0e6b701208784197aa9db81e18be7d0c
3 N1a2f12e93987417bbf5cc5a3ae0ec31a
4 N34f5d5f5cd5743baa9e10052f8e08c6c
5 N4213a1b072064bb5a66d1e19f5510348
6 N51095858342e48999edb88465255b212
7 N5856d7a874b2492aa4f70062566a1c0d
8 N6841c7107a5f4ec993321ff6b55a2631
9 N6a209739cdaa476aaa545553fd75aa0f
10 N6cbd4059a0d24c639bc1520168013c79
11 N8239efe7f912475ba56176e827e74934
12 N86008645359d4a93a2324187b53a88e0
13 N9d9e1a8bd1524f20ab04801e9ddbed56
14 N9dd65febc11b47c9be82bccbe6c16f78
15 Na95042d2439844649488ff8543d272e7
16 Nb3533edf396a4d1f8f3b2a77289946b9
17 Nb838142d7abe4496aa4d6f4a9e148f79
18 Ndb8d6dd8070a4fa6b43b1f044089aa2a
19 Ndfaed6f945fd4bc79e3a8359351c874c
20 Ne1ff50e4c25b44c89fc08e0905a514ca
21 anzsrc-for:11
22 anzsrc-for:1103
23 anzsrc-for:1112
24 schema:author Nb6cec2b501ea42dd9ff57c81339e0e31
25 schema:citation sg:pub.10.1007/s00259-001-0750-9
26 schema:datePublished 2003-10-31
27 schema:datePublishedReg 2003-10-31
28 schema:description The aim of this study was to compare the prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) with that of second-look laparotomy (SLL) in patients with advanced ovarian carcinoma following primary chemotherapy. Fifty-five patients who had undergone cytoreductive surgery and adjuvant chemotherapy for advanced ovarian carcinoma were enrolled in the study. Thirty patients underwent SLL after primary treatment (SLL group), while 25 underwent FDG PET after primary treatment without SLL (PET group). We retrospectively reviewed the medical records of the 55 patients for comparison of progression-free interval and disease-free interval between the two groups. Ovarian carcinomas recurred in 37 of the 55 patients. When the progression-free interval and the disease-free interval in patients in the PET group were compared with those in the SLL group, no significant differences were observed. The progression-free interval in the PET and SLL groups were 28.8±12.7 months and 30.6±13.7 months, respectively (P=0.29). The disease-free interval in the negative PET group was 40.5±11.6 months, and that in the negative SLL group was 48.6±12.1 months (P=0.12). In conclusion, FDG PET has a similar prognostic value to SLL, and can substitute for SLL in the follow-up of patients who have had ovarian carcinoma, especially when there is a high risk for recurrence.
29 schema:genre article
30 schema:isAccessibleForFree false
31 schema:isPartOf N20c5ce1233fb440fb854c8d2bdee6157
32 N24285a5c6c204c988880eea9741d4ac4
33 sg:journal.1297401
34 schema:keywords FDG-PET
35 PET
36 PET group
37 SLL group
38 adjuvant chemotherapy
39 advanced ovarian carcinoma
40 aim
41 carcinoma
42 chemotherapy
43 comparison
44 conclusion
45 cytoreductive surgery
46 differences
47 disease-free interval
48 emission tomography
49 fluorine-18 fluorodeoxyglucose positron emission tomography
50 fluorodeoxyglucose positron emission tomography
51 group
52 high risk
53 interval
54 laparotomy
55 medical records
56 months
57 ovarian carcinoma
58 patients
59 positron emission tomography
60 primary chemotherapy
61 primary treatment
62 prognostic value
63 progression-free interval
64 records
65 recurrence
66 risk
67 second-look laparotomy
68 significant differences
69 similar prognostic value
70 study
71 substitute
72 surgery
73 tomography
74 treatment
75 underwent FDG-PET
76 values
77 schema:name [18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma
78 schema:pagination 196-201
79 schema:productId N42b540c6bedd4c76ab99914ca9fc5fc6
80 N84bcad9d26d1436d8e80f6338e234612
81 Nf3a60fefa60b487f93c06db2887a898d
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007292516
83 https://doi.org/10.1007/s00259-003-1367-y
84 schema:sdDatePublished 2022-10-01T06:32
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher Nc8499ea980794aa1821ffd6a9e13dd95
87 schema:url https://doi.org/10.1007/s00259-003-1367-y
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N075091a5461543cb9ed2663c34fa10b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Second-Look Surgery
93 rdf:type schema:DefinedTerm
94 N0e6b701208784197aa9db81e18be7d0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Fluorodeoxyglucose F18
96 rdf:type schema:DefinedTerm
97 N1a2f12e93987417bbf5cc5a3ae0ec31a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Middle Aged
99 rdf:type schema:DefinedTerm
100 N20c5ce1233fb440fb854c8d2bdee6157 schema:volumeNumber 31
101 rdf:type schema:PublicationVolume
102 N24285a5c6c204c988880eea9741d4ac4 schema:issueNumber 2
103 rdf:type schema:PublicationIssue
104 N2c388d0c57da4b63a144f210253a742b rdf:first sg:person.012160052074.15
105 rdf:rest Na47f4ede41814652b5b9bf8d9ec7861d
106 N34f5d5f5cd5743baa9e10052f8e08c6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Reproducibility of Results
108 rdf:type schema:DefinedTerm
109 N4213a1b072064bb5a66d1e19f5510348 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Disease-Free Survival
111 rdf:type schema:DefinedTerm
112 N42b540c6bedd4c76ab99914ca9fc5fc6 schema:name doi
113 schema:value 10.1007/s00259-003-1367-y
114 rdf:type schema:PropertyValue
115 N4d6278ed648145829f9c1502c7f82e03 schema:affiliation grid-institutes:grid.412484.f
116 schema:familyName Kim
117 schema:givenName Sungeun
118 rdf:type schema:Person
119 N51095858342e48999edb88465255b212 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Ovarian Neoplasms
121 rdf:type schema:DefinedTerm
122 N5856d7a874b2492aa4f70062566a1c0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Humans
124 rdf:type schema:DefinedTerm
125 N5ba1ce67c1c8415f84c5e866bf2972b4 rdf:first sg:person.01301360400.94
126 rdf:rest Na99cab34c2d040ca8855c0e76881b6b3
127 N6841c7107a5f4ec993321ff6b55a2631 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Prognosis
129 rdf:type schema:DefinedTerm
130 N6a209739cdaa476aaa545553fd75aa0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Laparotomy
132 rdf:type schema:DefinedTerm
133 N6cbd4059a0d24c639bc1520168013c79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Follow-Up Studies
135 rdf:type schema:DefinedTerm
136 N8239efe7f912475ba56176e827e74934 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Analgesics
138 rdf:type schema:DefinedTerm
139 N84bcad9d26d1436d8e80f6338e234612 schema:name dimensions_id
140 schema:value pub.1007292516
141 rdf:type schema:PropertyValue
142 N86008645359d4a93a2324187b53a88e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Radiopharmaceuticals
144 rdf:type schema:DefinedTerm
145 N9ced458536b6481ebcf64e92303fe5ae rdf:first sg:person.01337220140.25
146 rdf:rest rdf:nil
147 N9d9e1a8bd1524f20ab04801e9ddbed56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Female
149 rdf:type schema:DefinedTerm
150 N9dd65febc11b47c9be82bccbe6c16f78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Treatment Outcome
152 rdf:type schema:DefinedTerm
153 Na057bf9c10774ca6b4bdef7bda7054ac rdf:first sg:person.0751347234.39
154 rdf:rest N2c388d0c57da4b63a144f210253a742b
155 Na47f4ede41814652b5b9bf8d9ec7861d rdf:first sg:person.01102164107.92
156 rdf:rest N5ba1ce67c1c8415f84c5e866bf2972b4
157 Na95042d2439844649488ff8543d272e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Adult
159 rdf:type schema:DefinedTerm
160 Na99cab34c2d040ca8855c0e76881b6b3 rdf:first Nb783f4fcb457437780a2befd6f8ca8af
161 rdf:rest N9ced458536b6481ebcf64e92303fe5ae
162 Nb3533edf396a4d1f8f3b2a77289946b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Tomography, Emission-Computed
164 rdf:type schema:DefinedTerm
165 Nb6cec2b501ea42dd9ff57c81339e0e31 rdf:first N4d6278ed648145829f9c1502c7f82e03
166 rdf:rest Na057bf9c10774ca6b4bdef7bda7054ac
167 Nb783f4fcb457437780a2befd6f8ca8af schema:affiliation grid-institutes:grid.412484.f
168 schema:familyName Lee
169 schema:givenName Dong Soo
170 rdf:type schema:Person
171 Nb838142d7abe4496aa4d6f4a9e148f79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Sensitivity and Specificity
173 rdf:type schema:DefinedTerm
174 Nc8499ea980794aa1821ffd6a9e13dd95 schema:name Springer Nature - SN SciGraph project
175 rdf:type schema:Organization
176 Ndb8d6dd8070a4fa6b43b1f044089aa2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Neoplasm Recurrence, Local
178 rdf:type schema:DefinedTerm
179 Ndfaed6f945fd4bc79e3a8359351c874c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Korea
181 rdf:type schema:DefinedTerm
182 Ne1ff50e4c25b44c89fc08e0905a514ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Aged
184 rdf:type schema:DefinedTerm
185 Nf3a60fefa60b487f93c06db2887a898d schema:name pubmed_id
186 schema:value 15129701
187 rdf:type schema:PropertyValue
188 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
189 schema:name Medical and Health Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
192 schema:name Clinical Sciences
193 rdf:type schema:DefinedTerm
194 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
195 schema:name Oncology and Carcinogenesis
196 rdf:type schema:DefinedTerm
197 sg:journal.1297401 schema:issn 1619-7070
198 1619-7089
199 schema:name European Journal of Nuclear Medicine and Molecular Imaging
200 schema:publisher Springer Nature
201 rdf:type schema:Periodical
202 sg:person.01102164107.92 schema:affiliation grid-institutes:grid.412484.f
203 schema:familyName Kim
204 schema:givenName Moon-Hong
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102164107.92
206 rdf:type schema:Person
207 sg:person.012160052074.15 schema:affiliation grid-institutes:grid.412484.f
208 schema:familyName Kang
209 schema:givenName Soon-Beom
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012160052074.15
211 rdf:type schema:Person
212 sg:person.01301360400.94 schema:affiliation grid-institutes:grid.412484.f
213 schema:familyName Jeong
214 schema:givenName Jae Min
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94
216 rdf:type schema:Person
217 sg:person.01337220140.25 schema:affiliation grid-institutes:grid.412484.f
218 schema:familyName Lee
219 schema:givenName Myung Chul
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337220140.25
221 rdf:type schema:Person
222 sg:person.0751347234.39 schema:affiliation grid-institutes:grid.412484.f
223 schema:familyName Chung
224 schema:givenName June-Key
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39
226 rdf:type schema:Person
227 sg:pub.10.1007/s00259-001-0750-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006601848
228 https://doi.org/10.1007/s00259-001-0750-9
229 rdf:type schema:CreativeWork
230 grid-institutes:grid.412484.f schema:alternateName Cancer Research Institute, Seoul National University Hospital, Seoul, Korea
231 Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea
232 Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea
233 schema:name Cancer Research Institute, Seoul National University Hospital, Seoul, Korea
234 Department of Nuclear Medicine, Seoul National University Hospital, 28 Yongon-dong, 110-744, Chongno-gu, Seoul, Korea
235 Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea
236 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...